
Sign up to save your podcasts
Or


Send us Fan Mail
We discuss Early Phase Clinical Trials with Dr Natalie Cook from the Christie Early Trials Unit.
We learn how molecular profiling is shaping early phase trials and how future trials may be shaped.
Send us Fan Mail
Clinical Trials are the Stepping Stones for the progress we have made over the years in the treatment of cancer.
We talk to Dr Mohini Varughese who is heavily involved in clinical trials in urology and passionate about the delivery of clinical trials across oncology.
We discuss:
🎙️Phase 1,2 &3 trials
💊The benefits for patients
💉The benefits for clinical teams
Send us Fan Mail
Join us as we return for Part 2 of our conversation with lead medical advisor to MacMillan - Dr Anthony Cunliffe.
Anthony is also a practising GP with ideas on how we can work better together - starting with how we keep our patients and GP teams up to date with our oncology letters.
We talk about Performance status and why it so important to us in oncology and also how we can make life easier for people to understand our letters without extra work.
The oncology letters from clinics are the lifeblood of information for many patients care so we should try and make them as useful as possible.
Send us Fan Mail
How we communicate is so important in all aspects of medicine.
In this special 2 part episode we look at demystifying the Language of Oncology.
Our letters go to GPs and patients and we speak to Dr Anthony Cunliffe who is the medical lead for Macmillan Cancer Support and a practising GP.
If you are GP or acute medic who treats cancer patients or a patient with access to your letters this is a MUST LISTEN.
Also those of us oncologists wanting to make our letters useful for GP teams there is a a LOT to learn!
We try and explain the meaning behind the letters.
He takes us to task about parts of our oncology letters that would be more useful for GPs and patients.
Send us Fan Mail
Join us for an episode looking at the role of radiotherapy in cancer treatment.
We discuss the principles of radiotherapy with Dr Grant Stewart who has 20 years experience with radiotherapy treatments.
This is a great episode for anyone wanting to understand the principles of radiotherapy.
IF you are a patient wanting to understand your treatment or a doctor or nurse wanting to know more about radiotherapy please check this out!
Send us Fan Mail
We are back again discussing stereotactic ablative body radiotherapy (SABR) with Dr Harshani Green from the Royal Marsden Hospital.
Join us if :
- You want to hear about the evidence from the FASTRACK II trial using renal SABR
- You are a centre thinking about setting up renal SABR
- You want to hear about the challenges of comparing renal SABR with surgery
Will radiotherapy be able to replace cytoreductive nephrectomy in metastatic renal carcinoma?
We discuss this and more (plus Mike produces a Magic Lamp!)
Enjoy
Send us Fan Mail
Join us for Part 1 of our 2 part Simply Oncology podcast with Dr Harshani Green on Stereotactic Ablative Body Radiotherapy (SABR) in Renal Cell Carcinoma.
We discuss the role of high precision radiotherapy treating renal cell carcinoma in those patients where an operation may not be possible.
- We discuss the excellent control rates
- What size of tumour can we treat?
- Will we ever be able to compare Surgery versus SABR for primary renal cell carcinoma cancers?
Send us Fan Mail
Surgery in Bladder Cancer Bumper episode!
We talk to Professor Jim Catto about surgery in Bladder Cancer.
🎙️we discuss the GUSTO trial stratifying bladder cancer therapy by molecular subtype
🎙️we look at quality of life and #cystectomy🎙️we look at surgical outcomes from NIAGARA
🎙️we look at peri-operative trials
A bumper Bladder Cancer issue
Send us Fan Mail
We welcome back Professor Tom Crosby for another episode on oesophageal cancer.
In the previous episode we focus on the diagnostic pathway. In this episode we look at option in the metastatic and advanced setting.
From the publisher's feed
Welcome to Simply Oncology.
Cancer is daunting for both patients and for clinical teams.
Dr John McGrane and Dr Michael Rowe are oncologists who want to break down the complex parts of…